Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines

Autoimmunity

Volumn 38, Issue 2, 2005, Pages 139-150

  Ganor, Yonatan ^a   Freilinger, Michael ^b   Dulac, Olivier ^c   Levite, Mia ^a,d  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF VIENNA   (Austria)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Cytokines; Epilepsy twins; Glutamate receptor GluR3; Rasmussen's encephalitis

Indexed keywords

AMINO ACID; AMPA RECEPTOR; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; CYTOKINE; DNA ANTIBODY; DOUBLE STRANDED DNA; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; PEPTIDE DERIVATIVE; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPILEPSY; FEMALE; HUMAN; MONOZYGOTIC TWINS; PATHOGENESIS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RASMUSSEN SYNDROME; STATISTICAL SIGNIFICANCE; TWIN DISCORDANCE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CYTOKINES; ENCEPHALITIS; EPILEPSY; FEMALE; HUMANS; TWINS, MONOZYGOTIC;

EID: 21044434795     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930500100825     Document Type: Article

References (58)

1. Ganor Y, Goldberg-Stern H, Amrom D, Lerman-Sagie T, Teichberg VI, Pelled D, Futerman AH, Ben-Zeev B, Freilinger M, Verheulpen D, Van Bogaert P, Levite M. Autoimmune epilepsy: Some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after Hemispherotomy. Clin Dev Immunol 2004;11:241-252.
2. Ganor Y, Goldberg-Stern H, Lerman-Sagie T, Teichberg VI, Levite M. Autoimmune epilepsy: Distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA (Revised) 2005.
3. Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002;131:179-185.
4. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-651.
5. Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J, Mantegazza R, Melms A. GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001;57:1511-1514.
6. Koustova E, Sei Y, Fossom L, Wei ML, Usherwood PN, Keele NB, Rogawski MA, Basile AS. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor. J Clin Investig 2001;107:737-744.
7. Levite M, Fleidervish IA, Schwarz A, Pelled D, Futerman AH. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun 1999;13:61-72.
8. He XP, Patel M, Whitney KD, Janumpalli S, Tenner A, McNamara JO. Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 1998;20:153-163.
9. Whitney KD, Andrews PI, McNamara JO. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology 1999;53:699-708.
10. Whitney KD, McNamara JO. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J Neurosci 2000; 20:7307-7316.
11. Xiong ZQ, McNamara JO. Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack. Neuron 2002;36:363-374.
12. Antozzi C, Granata T, Aurisano N, Zardini G, Confalonieri P, Airaghi G, Mantegazza R, Spreafico R. Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology 1998;51:302-305.
13. Levite M, Hermelin A. Autoimmunity to the glutamate receptor in mice-a model for Rasmussen's encephalitis? J Autoimmun 1999;13:73-82.
14. Ganor Y, Gottlieb M, Eilam R, Otmy H, Teichberg VI, Levite M. Immunization with the glutamate receptor derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures (Revised) 2005.
15. Levite M, Hart IK. Immunotherapy for epilepsy. Expert Rev Neurotherapeutics 2002;2:804-819.
16. Briellmann RS, Jackson GD, Torn-Broers Y, Berkovic SF. Causes of epilepsies: Insights from discordant monozygous twins. Ann Neurol 2001;49:45-52.
17. Brodtkorb E. Monozygous twins discordant for epilepsy. Ann Neurol 2002;51:137.
18. Schinzel A, Niedrist D. Chromosome imbalances associated with epilepsy. Am J Med Genet 2001;106:119-124.
19. Dulac O. Rasmussen's syndrome. Curr Opin Neurol 1996;9:75-77.
20. Granata T, Gobbi G, Spreafico R, Vigevano F, Capovilla G, Ragona F, Freri E, Chiapparini L, Bernasconi P, Giordano L, Bertani G, Casazza M, Dalla Bernardina B, Fusco L. Rasmussen's encephalitis: Early characteristics allow diagnosis. Neurology 2003;60:422-425.
21. Prayson RA, Frater JL. Rasmussen encephalitis: A clinico-pathologic and immunohistochemical study of seven patients. Am J Clin Pathol 2002;117:776-782.
22. Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8:435-445.
23. Rasmussen T. Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol 1978; 41:1-12.
24. Eilat E, Dayan M, Zinger H, Mozes E. The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc Natl Acad Sci USA 2001;98:1148-1153.
25. Lefvert AK, Link H. IgG production within the central nervous system: A critical review of proposed formulae. Ann Neurol 1985;17:13-20.
26. Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Investig 1977;37:397-401.
27. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338:1359-1368.
28. Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, Mozes E. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 2005;11:11.
29. Lascelles K, Dean AF, Robinson RO. Rasmussen's encephalitis followed by lupus erythematosus. Dev Med Child Neurol 2002;44:572-574.
30. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-1027.
31. Luzzana C, Gerosa M, Riboldi P, Meroni PL. Update on the antiphospholipid syndrome. J Nephrol 2002;15:342-348.
32. Cimaz R, Romeo A, Scarano A, Avcin T, Viri M, Veggiotti P, Gatti A, Lodi M, Catelli L, Panzeri P, Cecchini G, Meroni PL. Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia 2002;43:52-59.
33. George J, Gilburd B, Langevitz P, Levy Y, Nezlin R, Harats D, Shoenfeld Y. Beta2 glycoprotein I containing immune-complexes in lupus patients: Association with thrombocytopenia and lipoprotein (a) levels. Lupus 1999;8:116-120.
34. Shoenfeld Y, Gharavi A, Koike T. Beta2GP-I in the anti phospholipid (Hughes') syndrome-from a cofactor to an autoantigen-from induction to prevention of antiphospholipid syndrome. Lupus 1998;7:503-506.
35. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Investig 2002;109:797-804.
36. Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000;15:163-172.
37. Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 2003;170:4362-4372.
38. Petersen JS, Kyvik KO, Bingley PJ, Gale EA, Green A, Dyrberg T, Beck-Nielsen H. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus. BMJ 1997;314:1575-1579.
39. Redondo MJ, Rewers M, Yu L, Garg S, Pilcher CC, Elliott RB, Eisenbarth GS. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ 1999;318:698-702.
40. Bustabad S, Gonzalez T, Trujillo E. Systemic lupus erythematosus in childhood. Concordance in a pair of monozygotic twins for anti-dsDNA antibodies and discordance for disease expression. J Rheumatol 1997;24:1450-1451.
41. Lefvert AK, Pirskanen R, Eng H, Sundewall AC, Svanborg E. B cell and autoantibody repertoire in a pair of monozygotic twins discordant for myasthenia gravis. Clin Immunol Immunopathol 1989;53:161-170.
42. Murphy J, Murphy SF. Myasthenia gravis in identical twins. Neurology 1986;36:78-80.
43. Bergkvist M, Sandberg-Wollheim M. Serological differences in monozygotic twin pairs discordant for multiple sclerosis. Acta Neurol Scand 2001;104:262-265.
44. Kallmann BA, Lampeter EF, Hanifi-Moghaddam P, Hawa M, Leslie RD, Kolb H. Cytokine secretion patterns in twins discordant for Type I diabetes. Diabetologia 1999; 42:1080-1085.
45. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 2001;159:193-203.
46. Rose NR, Afanasyeva M, Wang Y, Kaya Z, Fairweather D. Infection to autoimmunity: The delicate balance. Autoimmun Rev 2002;1:14, (abstract).
47. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 2000;6:693-697.
48. Finsen B, Antel J, Owens T. TNFalpha: Kill or cure for demyelinating disease? Mol Psychiatr 2002;7:820-821.
49. Aarli JA. Role of cytokines in neurological disorders. Curr Med Chem 2003;10:1931-1937.
50. Liu ZS, Wang QW, Wang FL, Yang LZ. Serum cytokine levels are altered in patients with west syndrome. Brain Dev 2001;23:548-551.
51. Virta M, Hurme M, Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 2002;43:920-923.
52. Levite M. Autoimmune epilepsy. Nat Immunol 2002;3:500.
53. Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 2002;23:145-151.
54. Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. J Autoimmun 1996;9:295-300.
55. Hiepe F, Dorner T, Burmester G. Antinuclear antibody- and extractable nuclear antigen-related diseases. Int Arch Allergy Immunol 2000;123:5-9.
56. Eftekhari P, Salle L, Lezoualc'h F, Mialet J, Gastineau M, Briand JP, Isenberg DA, Fournie GJ, Argibay J, Fischmeister R, Muller S, Hoebeke J. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 2000;30:2782-2790.
57. Mavragani CP, Tzioufas AG, Moutsopoulos HM. Sjogren's syndrome: Autoantibodies to cellular antigens. Clinical and molecular aspects. Int Arch Allergy Immunol 2000; 123:46-57.
58. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus 2003;12:903-907.